Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.120
+0.020 (0.95%)
At close: Aug 11, 2026, 4:00 PM EDT
2.120
0.00 (0.00%)
Pre-market: Aug 12, 2026, 4:56 AM EDT

Allogene Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-173.76-190.89-257.59-327.27-340.41-182.05
Depreciation & Amortization
12.1312.3613.6414.214.310.45
Stock-Based Compensation
33.7437.6451.7465.9583.680.82
Other Adjustments
0.492.5216.7130.6918.1-62.08
Changes in Accounts Payable
-0.23-1.23-0.5-7.54.87-0.77
Changes in Accrued Expenses
-2.4-2.52-1.26-6.821.753.65
Changes in Unearned Revenue
-----0.02-38.3
Changes in Other Operating Activities
18.42-7.13-23.03-6.98-2.73.46
Operating Cash Flow
-109.23-149.25-200.3-237.73-220.52-184.81
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.3-0.39-0.69-1.52-5.19-21.45
Purchases of Investments
-189.73-138.26-361.48-438.63-248.11-525.58
Proceeds from Sale of Investments
249.82234.2437.86603.43359.46728.39
Other Investing Activities
------17.71
Investing Cash Flow
59.895.5675.69163.29106.16163.66

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
33.7323.25114.495.72.9511.96
Net Common Stock Issued (Repurchased)
33.7323.25114.495.72.9511.96
Other Financing Activities
3.566.912.28---
Financing Cash Flow
37.2930.16116.6895.72.9511.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-12.15-23.53-7.9421.25-111.41-9.19

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-109.53-149.63-200.99-239.25-225.71-206.26
Free Cash Flow Growth
------
FCF Margin
---913609.00%-251841.00%-144686.00%-180.79%
Free Cash Flow Per Share
-0.48-0.68-1.03-1.52-1.58-1.52
Levered Free Cash Flow
-146.14-189.79-269.44-335.89-327.41-224.99
Unlevered Free Cash Flow
-162.6-208.22-285.52-336.36-322.54-223.13
SEC Filings: 10-K · 10-Q